로딩 중…
지수 로딩 중…
Dianthus Therapeutics, Inc.
DNTH· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$82.49+0.73%
2026-06-18
Price Chart
Dianthus Therapeutics, Inc.+372.99%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $4.51B |
| Revenue | $1M |
| Net Income | $-11M |
| Total Assets | $1.25B |
| Net Assets | $1.20B |
| Value | |
| P/B | 3.75x |
| FCF Yield | -2.89% |
| Profitability | |
| ROE | -0.94% |
| ROA | -0.91% |
| Op. Margin | -14318.04% |
| Revenue Growth | -60.19% |
| Financial Health | |
| Debt Ratio | 3.79% |
| Total Debt | $1M |
| FCF | $-130M |
| Cash | $628M |
| Current Ratio | 29.25x |
| Performance | |
| 1Y Return | 372.99% |
| 1M Return | -3.71% |
| From 52W High | -14.52% |
| 1Y MDD | -21.35% |
| Trading | |
| Volume | 1,765,711 shares |
| Trading Value | $145M |
| Per Share | |
| BPS | $13.05 |